SAVANNAH FOODS & INDUSTRIES INC
S-3/A, 1996-05-10
SUGAR & CONFECTIONERY PRODUCTS
Previous: ROHM & HAAS CO, 10-Q, 1996-05-10
Next: SCIENTIFIC SOFTWARE INTERCOMP INC, SC 13G/A, 1996-05-10




   
   As filed with the Securities and Exchange Commission on May 10, 1996
                                        Registration No. 333-2005    
                                                                      

                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549

                         __________________________

                                  FORM S-3

                           REGISTRATION STATEMENT
                                   UNDER
                         THE SECURITIES ACT OF 1933
   
                              AMENDMENT NO. 1
    
                             __________________

                               SAVANNAH FOODS
                             & INDUSTRIES, INC.
           (Exact name of registrant as specified in its charter)

          Delaware                                     58-1089367
     (State or other jurisdiction of       (I.R.S. Employer Identification No.)
      incorporation or organization)
                                P.O. Box 339
                       Savannah, Georgia  31402-0339
                               (912) 234-1261
             (Address, including zip code, and telephone number
          including area code, of registrant's executive offices)
                        ___________________________

                             Gregory H. Smith
                          Senior Vice President, 
                         Chief Financial Officer
                             and Treasurer
                    Savannah Foods & Industries, Inc.
                              P.O. Box 339
                        Savannah, Georgia  31402
                             (912) 234-1261
          (Name, address, including zip code, and telephone number,
                     including area code, of agent for service)
                           ___________________________

                               With a copy to:

                             Daniel E. Stoller
                    Skadden, Arps, Slate, Meagher & Flom
                               919 Third Avenue
                          New York, New York  10022
                                (212) 735-3000
                         ___________________________

     Approximate date of commencement of proposed sale to the public: 
     As soon as practicable after the registration statement becomes
     effective.

     If the only securities being registered on this Form are being
     offered pursuant to dividend or interest reinvestment plans,
     please check the following box.  ( )

     If any of the securities being registered on this Form are to be
     offered on a delayed or continuous basis pursuant to Rule 415
     under the Securities Act of 1933, other than securities offered
     only in connection with dividend or interest reinvestment plans,
     check the following box.  (X)

       
                          ______________________

     The Registrant hereby amends this Registration Statement on such
     date or dates as may be necessary to delay its effective date
     until the Registrant shall file a further amendment which specif-
     ically states that this Registration Statement shall thereafter
     become effective in accordance with Section 8(a) of the Securi-
     ties Act of 1933 or until this Registration Statement shall
     become effective on such date as the Commission, acting pursuant
     to said Section 8(a), may determine.


                                PROSPECTUS

                             2,500,000 SHARES

                             SAVANNAH FOODS
                            & INDUSTRIES, INC.

                              COMMON STOCK 

     This Prospectus relates to up to 2,500,000 shares (the "Shares")
     of the common stock, par value $0.25 per share (the "Common
     Stock"), of Savannah Foods & Industries, Inc., a Delaware corpo-
     ration (the "Company"), that may be sold from time to time by the
     trustee of the Savannah Foods & Industries, Inc. Benefit Trust
     (the "Benefit Trust").  

     The Common Stock offered hereby may be sold from time to time in
     one or more of the following transactions: (a) to underwriters
     who will acquire the shares for their own account and resell them
     in one or more transactions, including negotiated transactions,
     at a fixed price or at varying prices determined at the time of
     sale; any initial public offering price and any discounts or
     concessions allowed or reallowed or paid to dealers may be
     changed from time to time; (b) through brokers or dealers, acting
     as principal or agent, in transactions (which may involve block
     transactions) on the New York Stock Exchange, in special offer-
     ings, exchange distributions pursuant to the rules of the appli-
     cable exchanges or in the over-the-counter market, or otherwise,
     at market prices prevailing at the time of sale, at prices
     related to such prevailing market prices, at negotiated prices or
     at fixed prices; or (c) directly through brokers or agents in
     private sales at negotiated prices.  Underwriters participating
     in any offering may receive underwriting discounts and commis-
     sions and discounts or concessions may be allowed or reallowed or
     paid to dealers, and brokers or agents participating in such
     transactions may receive brokerage or agent's commissions or
     fees.  To the extent required, the aggregate amount of Common
     Stock being offered and the terms of the offering, the names of
     any such agents, dealers or underwriters and any applicable
     commission with respect to a particular offer will be set forth
     in an accompanying Prospectus Supplement.

     The aggregate proceeds to the Benefit Trust from the sale of the
     Common Stock will be the selling price of the Common Stock.  The
     Company will pay all of the expenses of this offering, including
     commissions and discounts of agents, dealers or underwriters. 
     Such expenses, excluding commissions and discounts, are estimated
     to be approximately $51,767.  None of the proceeds from the sale
     of the Common Stock offered hereby will be received for the
     benefit of, or retained by, the Company.

     The Company, or one of its subsidiaries, as the case may be, has
     agreed to indemnify the trustee of the Benefit Trust against
     certain liabilities that may arise in connection with their
     performance of duties pursuant to the Benefit Trust.  See "Plan
     of Distribution".

     The trustee of the Benefit Trust, the Benefit Trust and any
     agents, dealers or underwriters that participate in the distribu-
     tion of the Common Stock offered hereby may be deemed to be
     "underwriters" within the meaning of the Securities Act of 1933,
     as amended (the "Securities Act"), and any commissions received
     by them and any profit on the resale of the Common Stock pur-
     chased by them may be deemed underwriting commissions or dis-
     counts under the Securities Act.
                                                
     SEE "RISK FACTORS" FOR A DISCUSSION OF CERTAIN FACTORS THAT
     SHOULD BE CONSIDERED BY PROSPECTIVE PURCHASERS OF THE COMMON
     STOCK OFFERED HEREBY.

     THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
     SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES 
     COMMISSION NOR HAS THE SECURITIES AND EXCHANGE COMMISSION 
     OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY 
     OR ADEQUACY OF THIS PROSPECTUS.  ANY REPRESENTATION TO THE 
     CONTRARY IS A CRIMINAL OFFENSE.

     The date of this Prospectus is                  , 1996



                           AVAILABLE INFORMATION

          The Company is subject to the informational requirements of
     the Securities Exchange Act of 1934, as amended (the "Exchange
     Act"), and in accordance therewith files reports, proxy state-
     ments, and other information with the Securities and Exchange
     Commission (the "Commission").  Such reports, proxy statements,
     and other information filed by the Company can be inspected and
     copied at the public reference facilities maintained by the
     Commission at 450 Fifth Street, N.W., Washington, D.C. 20549; as
     well as at the Regional Offices of the Commission at 7 World
     Trade Center, New York, New York 10048; and 500 West Madison
     Street, Chicago, Illinois 60661.  Copies of such material can be
     obtained (at prescribed rates) from the Public Reference Section
     of the Commission at 450 Fifth Street, N.W.,  Washington, D.C.
     20549.  The Common Stock is listed on the New York Stock Ex-
     change.  Reports, proxy statements, and other information con-
     cerning the Company can be inspected at the office of such
     Exchange, located at 20 Broad Street, New York, New York 10005.

          This Prospectus constitutes a part of a Registration State-
     ment filed by the Company with the Commission under the Securi-
     ties Act.  This Prospectus omits certain of the information
     contained in the Registration Statement, and reference is hereby
     made to the Registration Statement and related exhibits for
     further information with respect to the Company and the Shares
     offered hereby.  Any statements contained herein concerning the
     provisions of any document are not necessarily complete, and, in
     each instance, reference is made to the copy of such document
     filed as an exhibit to the Registration Statement or otherwise
     filed with the Commission.  Each such statement is qualified in
     its entirety by such reference.

          The Company is incorporated under the laws of Delaware.  Its
     principal executive offices are located at 2 East Bryan Street,
     Savannah, Georgia 31401 (telephone (912) 234-1261).

              INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

          The following documents filed with the Commission pursuant
     to the Exchange Act are incorporated herein by reference and
     shall be deemed to be a part hereof:

          1.   Annual Report on Form 10-K for the fiscal year ended
     October 1, 1995.

          2.   Proxy Statement dated January 11, 1996, relating to the
               Company's 1996 Annual Meeting of Stockholders.

          3.   Quarterly Report on Form 10-Q for the period ended
               December 31, 1995.

          All documents filed by the Company pursuant to Section
     13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the
     date of this Prospectus and prior to the termination of the
     offering of the Shares covered by this Prospectus are deemed to
     be incorporated by reference herein and shall be a part hereof
     from their respective dates of filing.

          Any statement contained in a document incorporated by
     reference herein shall be deemed to be modified or superseded for
     purposes of this Prospectus to the extent that a statement
     contained in this Prospectus or in any other subsequently filed
     document that also is incorporated by reference herein modifies
     or supersedes such statement.  Any such statement so modified or
     superseded shall not be deemed, except as so modified or super-
     seded, to constitute a part of this Prospectus.

          The Company will provide, without charge, to each person,
     including any beneficial owner, to whom a copy of this Prospectus
     is delivered, upon written or oral request, a copy of any and all
     of the information that has been incorporated by reference in
     this Prospectus, but not including exhibits to such information
     unless such exhibits are specifically incorporated by reference
     into the information that this Prospectus incorporates.  Requests
     for copies of such information should be directed to Vice Presi-
     dent -Administration, Savannah Foods & Industries, Inc., Post
     Office Box 339, Savannah, Georgia 31402-0339.

                                THE COMPANY

          The Company was incorporated in Delaware on February 19,
     1969, as the successor to Savannah Sugar Refining Corporation,
     which was originally incorporated in New York in 1916.

          The Company and its subsidiaries collectively comprise one
     business segment and are engaged in the production, marketing,
     and distribution of food products, primarily refined sugar.

          Effective October 2, 1995, the first day of fiscal 1996, the
     Company reorganized the business structure of several of its
     subsidiaries.  This reorganization did not affect the overall
     business of the Company, but was done primarily for internal
     management purposes.

          The Company and its wholly-owned subsidiaries, Savannah
     Foods Industrial, Inc. and Dixie Crystals  Brands, Inc., are
     engaged in the refining and marketing of a complete line of bulk
     and liquid sugars and sugar products, including edible molasses,
     liquid animal feeds and corn syrup blends.  They also produce and
     market a complete line of packaged sugars and portion control
     items consisting of sugar envelopes, artificial sweeteners, salt,
     pepper, non-dairy creamer, and certain other products.  Industri-
     al and grocery products are marketed primarily in the southeast-
     ern portion of the United States, Louisiana, and Texas, but are
     also widely distributed into other states generally east of the
     Mississippi and south of New England.  Foodservice products are
     marketed throughout the United States.  Products are marketed
     under the trade names Dixie Crystals(R), Colonial(R), Evercane(R), and
     Savannah Gold(R), but are also sold under the Company's other
     controlled labels and under customers' private label brands.  The
     Company's saccharin-based sweetener is marketed under the trade
     name Sweet Thing(R) and its aspartame-based sweetener is marketed
     under the trade name Sweet Thing II(R).  These products are market-
     ed both by means of direct sales and through brokers and are
     primarily distributed directly to the customer by common carrier
     truck or railcar.

          Michigan Sugar Company, a wholly-owned subsidiary of the
     Company, and its wholly-owned subsidiary, Great Lakes Sugar
     Company, are engaged in the processing of sugar beets into
     refined sugar and the production of beet pulp and molasses.  The
     refined sugar is marketed primarily in the states of Michigan and
     Ohio, but is also distributed in the midwestern and eastern parts
     of the United States.  Packaged sugar is marketed under the trade
     name PIONEER(R), but is also sold under customers' private label
     brands.  These products are marketed both by means of direct
     sales and through brokers and are primarily distributed directly
     to the customer by common carrier truck or railcar.  Most of the
     beet pulp is pelletized and sold for export.  The balance is sold
     in the domestic market.  The majority of the molasses is sold to
     the Company's beet molasses desugarization facility for further
     processing to recover additional sugar.

          King Packaging Company, Inc., a wholly-owned subsidiary of
     Dixie Crystals(R) Brands, Inc., packs custom made meal kits for the
     food service industry and provides complementary products to the 
     portion control products manufactured at the Company's other
     locations.  These products are marketed to the food service trade
     throughout the United States both by means of direct sales and
     through brokers and are primarily shipped directly to customers
     by common carrier truck.

          Raceland Sugars, Inc., a wholly-owned subsidiary of Savannah
     Foods Industrial, Inc., operates a raw sugar mill and is engaged
     in the business of producing raw sugar which is marketed in the 
     Louisiana area.  Additionally, the by-products, molasses and
     bagasse, are currently sold in the domestic market.

                                RISK FACTORS

          The Company's business and results of operations are sub-
     stantially affected by market factors, principally the domestic
     prices for refined sugar and raw sugar cane.  These market
     factors are influenced by a variety of forces, including weather
     conditions, competition, and United States farm and trade poli-
     cies. 

          The principal legislation presently affecting the domestic
     sugar industry is the Food, Agriculture, Conservation and Trade
     Act (the "Act"), which became effective October 1, 1991, and
     governs the sugar price support program for sugar cane and sugar
     beets.  The domestic marketplace demands approximately 9.5
     million tons of refined sugar annually.  To meet this demand,
     sugar beets and sugar cane are grown domestically, which are
     inadequate supplies to meet consumption demands.  As a result, a
     restriction is placed on the quantity of foreign raw sugar that
     is imported into the country to balance the supply for the
     marketplace.  The imported raw sugar restriction is referred to
     as the tariff-rate quota which was authorized under the General
     Agreement on Tariff and Trade.  To maintain a viable cane sugar
     refining industry and to ensure minimum raw sugar market for the
     traditional offshore suppliers of raw sugar to the United States,
     the minimum tariff-rate quota is 1,250,000 short tons raw value
     annually.  The quota can be increased from the annual minimum
     amount to compensate for domestic crop shortfalls.  The quota can
     also be utilized to maintain a certain level of domestic raw
     sugar trading prices.

          The administration of the sugar program described above is
     primarily the responsibility of the United States Department of
     Agriculture (the "USDA").  It is difficult to predict how the
     USDA will administer the sugar program which, together with
     market dynamics, could positively or negatively affect the
     profitability of the Company.

          The sugar program, together with all farm legislation, is
     currently being reviewed for change, but changes in current
     legislation cannot be predicted.  Additionally, the effectiveness
     of the future administration of the sugar program cannot be
     predicted.  Consequently, the Company is unable to predict the
     outcome of future legislative changes and administration changes,
     and the effect these factors may have on the result of operations
     of the Company.


                            PLAN OF DISTRIBUTION

          On March 14, 1996, the Company and Wachovia Bank of North
     Carolina, N.A., as trustee of the Benefit Trust, entered into a
     trust agreement creating the Benefit Trust.  The Company sold
     2,500,000 shares of Common Stock to the Benefit Trust in exchange
     for a promissory note in the amount of $26,875,000 (the "Promis-
     sory Note").

          The Benefit Trust was created to prefund certain of the
     Company's obligations under its employee benefit plans, including
     deferred compensation plans, supplemental executive retirement
     plans, employee stock ownership plans and defined benefit pension
     plans (collectively, the "Benefit Plans"). Shares of Common Stock
     will be held in the Benefit Trust and will constitute collateral
     for the loan evidenced by the Promissory Note.  On each date on
     which a payment or prepayment is made of any principal amount of
     the Promissory Note, the trustee of the Benefit Trust will
     release from collateral a certain number of Shares and will apply
     them, along with any other Benefit Trust assets to (i) the
     payment of indebtedness to the Company, (ii) the satisfaction of
     the Company's obligations under the Benefit Plans, (iii) the 
     reimbursement of payments made by the Company in satisfaction of
     such obligations, or (iv)  the acquisition of additional equity
     securities of the Company.

          This Prospectus relates to the shares of Common Stock owned
     by the Benefit Trust.  The number of shares of Common Stock that
     will be sold from time to time in the market by the trustee of
     the Benefit Trust will depend upon a number of factors, including
     the number of participants, and the forms of benefits and level
     of benefits to be provided under such Benefit Plans, the market
     price of the Common Stock and the benefit payment cycles under
     the various Benefit Plans.

          The Company will pay all of the expenses incident to the
     registration, offering and sale of the Common Stock to the
     public, including commissions and discounts of agents, dealers or
     underwriters.  The Company or one of its subsidiaries, as the
     case may be, has agreed to indemnify the trustee of the Benefit
     Trust against certain liabilities that may arise in connection
     with its performance of duties pursuant to the Benefit Trust.

          The Common Stock offered hereby may be sold from time to
     time in one or more of the following transactions:  (a) to
     underwriters who will acquire the shares for their own account
     and resell them in one or more transactions, including negotiated
     transactions, at a fixed price or at varying prices determined at
     the time of sale; any initial public offering price and any
     discounts or concessions allowed or reallowed or paid to dealers
     may be changed from time to time; (b) through brokers or dealers,
     acting as principal or agent, in transactions (which may involve
     block transactions) on the New York Stock Exchange, in special
     offerings, exchange distributions pursuant to the rules of the
     applicable exchanges or in the over-the-counter market, or
     otherwise, at market prices prevailing at the time of sale, at
     prices related to such prevailing market prices, at negotiated
     prices or at fixed prices; or (c) directly or through brokers or
     agents in private sales at negotiated prices.  Underwriters
     participating in any offering may receive underwriting discounts
     and commissions and discounts or concessions may be allowed or 
     reallowed or paid to dealers, and brokers or agents participating
     in such transactions may receive brokerage or agent's commissions
     or fees.  To the extent required, the aggregate amount of the
     Common Stock being offered and the terms of the offering, the
     names of any such agents, brokers, dealers or underwriters and
     any applicable commission with respect to a particular offer will
     be set forth in an accompanying Prospectus Supplement.

          The underwriters, brokers, dealers or agents who participate
     in the sale of the Shares may be deemed "underwriters" within the
     meaning of Section 2(11) of the Securities Act and the commission
     paid or discounts allowed to any of such underwriters, brokers,
     dealers or agents in addition to any profits received on resale
     of the Shares if any such underwriters, brokers, dealers or
     agents should purchase any Shares as a principal may be deemed to
     be underwriting discounts or commissions under the Securities Act
     of 1933.

          Certain of the underwriters, dealers, brokers or agents may
     have other business relationships with the Company and its
     affiliates in the ordinary course of business.

          Under applicable rules and regulations of the Exchange Act,
     any person engaged in the distribution of the Shares may not be
     simultaneously engaged in market making activities with respect 
     to the Common Stock for a period of nine business days prior to
     the later of the commencement of offers or sales of the Shares to
     be distributed and the time such person becomes a participant in
     the distribution.  In addition to and without limiting the
     generality of the foregoing, the Benefit Trust, the Company and 
     any other persons participating in such distribution will be
     subject to applicable provisions of the Exchange Act and rules
     and regulations thereunder, including without limitation Rules
     10b-6 and 10b-7, which provisions may limit the timing of pur-
     chases and sales of shares of Common Stock by the Benefit  Trust,
     the Company and any other such person.  All of the foregoing may
     limit the marketability of the Shares and the ability of any
     underwriter, broker, dealer or agent to engage in market making
     activities.

                          THE SELLING STOCKHOLDER

          The 2,500,000 shares of Common Stock offered in this Pro-
     spectus are owned by the Benefit Trust.

          The trustee of the Benefit Trust is the beneficial owner of
     2,500,000 shares or approximately 8.7%  of the Common Stock.  The
     trustee of the Benefit Trust has sole voting and investment power
     with respect to the Common Stock held in the Benefit Trust.  The
     Company may, pursuant to the terms of the trust agreement creat-
     ing the Benefit Trust, direct the trustee to make distributions
     from the assets of the Benefit Trust to the Benefit Plans main-
     tained by the Company in satisfaction of the Company's obliga-
     tions under those plans.

                        DESCRIPTION OF COMMON STOCK

          The following summary is subject to the detailed provisions
     of, and is qualified in its entirety by reference to, the
     Company's Certificate of Incorporation and By-Laws, copies of
     which have been incorporated by reference as exhibits to the
     Registration Statement of which this Prospectus is a part.  The
     authorized capital stock of the Company consists of 64 million
     shares of Common Stock, par value $.25 per share, and 1 million
     shares of preferred stock, par value $.50 per share.

     COMMON STOCK

          The Company's authorized common stock consists of 64 million
     shares of Common Stock, par value $.25 per share.  As of December
     31, 1995, there were 26,238,196 shares of Common Stock outstand-
     ing.

          Voting Rights

          Each share of Common Stock entitles the holder thereof to
     one vote in all matters submitted to a vote of stockholders.  The
     Common Stock does not have cumulative voting rights, which means
     that holders of a majority of the outstanding Common Stock voting
     for the election of directors can elect all directors then being
     elected.

          Dividends

          Subject to the rights of any preferred stock which may be
     issued by the Board of Directors, each share of Common Stock has
     an equal and ratable right to receive dividends to be paid from
     the Company's assets legally available therefor when, as and if
     declared by the Board of Directors.

          Liquidation

          In the event of the dissolution, liquidation or winding up
     of the Company, the holders of Common Stock are entitled to share
     equally and ratably in the assets available for distribution
     after payments are made to the Company's creditors and to the
     holders of any preferred stock of the Company that may be out-
     standing at the time.

          Other

          The holders of shares of Common Stock have no preemptive,
     subscription, redemption or conversion rights and are not liable
     for further call or assessment.  All of the outstanding shares of
     Common Stock are fully paid and nonassessable.

          Registrar and Transfer Agent

          Wachovia Bank of North Carolina, N.A. acts as Registrar and
     Transfer Agent for the Common Stock.

     PREFERRED STOCK

          The Company's Certificate of Incorporation provides that the
     Company may issue up to 1 million shares of preferred stock and
     the Board of Directors of the Company is authorized, without
     further stockholder action, to divide any or all shares of
     authorized preferred stock into series and to fix the redemption
     and liquidation value, dividend rate, voting rights, conversion
     privilege, preferences, maturity dates and other qualifications,
     limitations or restrictions.  As of the date of this Prospectus,
     the Board of Directors of the Company has not authorized any
     series of preferred stock and there are no plans, agreements or
     understandings for the issuance of any shares of preferred stock.

     CERTIFICATE OF INCORPORATION AND BY-LAWS

          Certain provisions of the Company's Certificate of Incorpo-
     ration and By-Laws could make more difficult non-negotiated
     acquisitions of the Company.  The Board of Directors believes
     that these provisions will help to assure the continuity and
     stability of the Board of Directors and the business strategies
     and policies of the Company as determined by the Board of Direc-
     tors.  These provisions could have the effect, however, of
     discouraging a third party from making a tender offer or other-
     wise attempting to obtain control of the Company even though such
     an attempt might be beneficial to the Company and its stockhold-
     ers.

          Pursuant to the Company's By-Laws, the Board of Directors of
     the Company is divided into three classes serving staggered
     three-year terms.  Directors can be removed from office with or
     without cause by the affirmative vote of 75% of the holders of
     the outstanding shares of capital stock entitled to vote  gener-
     ally in an election of directors.  Alternatively, any director
     may be removed for cause at any time by the affirmative vote of a
     majority of the directors then in office.  Vacancies on the Board
     of Directors may be filled only by vote of the remaining direc-
     tors and not by the stockholders.

          The Certificate of Incorporation provides that any action
     required or permitted to be taken by the stockholders of the
     Company may be effected only at an annual or special meeting of
     stockholders.  The Company's By-Laws provide that special meet-
     ings of stockholders may be called only by the chairman, the
     president or by order of the Board of Directors.

          The By-Laws establish an advance notice procedure for the
     nomination, other than by or at the direction of the Board of
     Directors, of candidates for election as directors at annual or
     special meetings of stockholders, as well as for other stockhold-
     er proposals to be considered at annual meetings of  stockhold-
     ers.  In general, (a) notice of intent to nominate a director or
     raise business at annual meetings must be received by the Company
     not less than 60 nor more than 90 days prior to the anniversary
     date of the previous year's annual meeting; provided, however,
     that in the event that the annual meeting is called for a date
     that is not within thirty days before or after such anniversary
     date, notice by the stockholder in order to be timely must be so
     received not later than the close of business on the tenth day
     following the day on which such notice of the date of the annual
     meeting was mailed or such public disclosure of the date of the
     annual meeting was made, whichever first occurs; and (b) notice
     of intent to nominate a director at special meetings must be
     received by the Company not later than the close of  business on
     the tenth day following the day on which notice of the date of
     the special meeting was mailed or public disclosure of the date
     of the special meeting was made, whichever first occurs.  All
     notices must contain certain specified information concerning the
     person to be nominated or the matters to be brought before the
     meeting and concerning the stockholder submitting the proposal.

          The foregoing summary is qualified in its entirety by the
     provisions of the Company's Certificate of Incorporation and By-
     Laws, copies of which have been incorporated by reference as
     exhibits to the Registration Statement of which this Prospectus
     constitutes a part.

                               LEGAL MATTERS

          The validity of the issuance of the shares of Common Stock
     offered hereby has been passed upon for the Company by Skadden,
     Arps, Slate, Meagher & Flom.

                                  EXPERTS

          The financial statements incorporated in this Prospectus by
     reference to the Annual Report on Form 10-K for the year ended
     October 1, 1995, have been so incorporated in reliance on the
     report of Price Waterhouse LLP, independent accountants, given on
     the authority of said firm as experts in auditing and accounting.
                                                                           
                                                        
      No person has been authorized to
      give any information or to make
      any representation not contained
      in this Prospectus and, if given
      or made, such information or rep-
      resentation must not be relied
      upon as having been authorized by
      the Company.  This Prospectus does
      not constitute an offer to sell or
      a solicitation of an offer to buy
      any of the securities offered
      hereby in any jurisdic tion to any          SAVANNAH FOODS &
      person to whom it is unlawful to            INDUSTRIES, INC.
      make such offer in such jurisdic-
      tion.  Neither the delivery of              2,500,000 SHARES
      this Prospectus nor any sale made
      hereunder shall, under any circum-            Common Stock
      stances, create any implication
      that the information herein is
      correct as of any time subsequent
      to the date hereof or that there
      has been no change in the affairs
      of the Company since such date.

            _____________________                    PROSPECTUS

           TABLE OF CONTENTS        PAGE

      AVAILABLE INFORMATION.......   5    

      INCORPORATION OF CERTAIN  
       DOCUMENTS BY REFERENCE ....   5    

      THE COMPANY ................   6    
                                                           , 1996
      RISK FACTORS ...............   7    

      PLAN OF DISTRIBUTION........   8    

      THE SELLING STOCKHOLDER......  9    

      DESCRIPTION OF COMMON STOCK..  9    

      LEGAL MATTERS ............... 11    

      EXPERTS ....................  12    


                                  PART II

                   INFORMATION NOT REQUIRED IN PROSPECTUS

     Item 14.  Other Expenses of Issuance and Distribution

     Securities and Exchange Commission filing fee   . . .  $  9,267  
     Accounting fees and expenses   . . . . . . . . . . . . .  7,500*
     Legal fees and expenses  . . . . . . . . . . . . . . . . 30,000*
     Miscellaneous  . . . . . . . . . . . . . . . . . . . . .  5,000*
        Total . . . . . . . . . . . . . . . . . . . . . . . . 51,767*

     ___________
     *Estimated

     Item 15.  Indemnification of Directors and Officers

          Subsection (b)(7) of Section 102 of the General Corporation
     Law of the State of Delaware (the "GCL") empowers a corporation
     in its original certificate of incorporation or an amendment
     thereto validly approved by stockholders to eliminate or limit
     the personal liability of a director to the corporation or its
     stockholders for monetary damages for breach of fiduciary duty as
     a director, provided that such provision cannot eliminate or
     limit the liability of a director for (i) breach of his duty of
     loyalty, (ii) acts or omissions not in good faith or which
     involve intentional misconduct or knowing violation of law, (iii)
     payment of a stock dividend or approval of a stock repurchase
     which was illegal under Section 174 of the GCL or (iv) any
     transaction from which he derived an improper personal benefit.

          Reference is made to Section 145 of the GCL relating to the
     indemnification of directors and officers of a Delaware corpora-
     tion.

          Article Ninth of the Company's Amended Certificate of
     Incorporation provides for limitation of liability of directors,
     and indemnification of directors, officers and others as follows:

               NINTH:  No Director shall be personally liable to
          the Corporation or any stockholder for monetary damages
          for breach of fiduciary duty as a Director, except for 
          any matter in respect of which such Director shall be
          liable under Section 174 of Title 8 of the Delaware
          Code (relating to the Delaware General Corporation Law)
          or any amendment thereto or successor provision thereto
          or shall be liable by reason that, in addition to any
          and all other requirements for such liability, he (i)
          shall have breached his duty of loyalty to the Corpora-
          tion or its stockholders, (ii) shall not have acted in
          good faith or, in failing to act, shall not have acted
          in good faith, (iii) shall have acted in a  manner
          involving intentional misconduct or a knowing violation
          of law or, in failing to act, shall have acted in a
          manner involving intentional misconduct or a knowing
          violation of law, or (iv) shall have derived an improp-
          er personal benefit.  Neither the amendment nor repeal
          of this Article Ninth, nor the adoption of any provi-
          sion of the Certificate of Incorporation inconsistent
          with this Article Ninth shall eliminate or reduce the
          effect of this Article Ninth in respect of any matter
          occurring, or any cause of action, suit, or claim that,
          but for this Article Ninth would accrue or arise, prior
          to such amendment.

          Article VI of the Company's By-Laws provides that the
     Corporation shall, to the fullest extent permitted by Section 145
     of the GCL, indemnify any and all persons whom it shall have
     power to indemnify under said Section from and against any and
     all of the expenses, liabilities or other matters referred to in,
     or covered by said Section.

     Item 16.  Exhibits

          The following exhibits are filed as part of this Registra-
     tion Statement:

     Exhibit No.    Description
   
     3(i)*          Certificate of Incorporation of the Company with
                    Amendments adopted through May 24, 1990.

     3(ii)*         By-Laws of the Company.

     5.1            Opinion of Skadden, Arps, Slate, Meagher & Flom.

     23.1           Consent of Price Waterhouse LLP.

     23.2           Consent of Skadden, Arps, Slate, Meagher & Flom 
                    (included in Exhibit 5.1).

     99.1           Benefit Trust Agreement.

     *  Previously filed.    

     Item 17.  Undertakings

          (a)  The Company hereby undertakes:

               1.   To file, during any period in which offers or
     sales are being made, a post-effective amendment to this regis-
     tration statement:

                    (i)  To include any prospectus required by Section
                         10(a)(3) of the Securities Act;

                    (ii) To reflect in the prospectus any facts or
                         events arising after the effective date of
                         the registration statement (or the most re-
                         cent post-effective amendment thereof) which,
                         individually or in the aggregate, represent a
                         fundamental change in the information set
                         forth in the registration statement. Notwith-
                         standing the foregoing, any increase or de-
                         crease in volume of securities offered (if
                         the total dollar value of securities offered
                         would not exceed that which was registered)
                         and any deviation from the low or high and of
                         the estimated maximum offering range may be
                         reflected in the form of prospectus filed
                         with the Commission pursuant to Rule 424(b)
                         if, in the aggregate, the changes in volume
                         and price represent no  more than 20 percent
                         change in the maximum aggregate offering
                         price set forth in the "Calculation of Regis-
                         tration Fee" table in the effective registra-
                         tion statement;

                  (iii)  To include any material information with
                         respect to the plan of distribution not
                         previously disclosed in the registration
                         statement or any material change to such
                         information in the registration state-
                         ment;

     provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do
     not apply if the information required to be included in a post-
     effective amendment by those paragraphs is contained in periodic
     reports filed by the Company pursuant to Section 13 or Section
     15(d) of the Exchange Act that are incorporated by reference in
     the registration statement.

               2.   That, for the purpose of determining any liability
     under the Securities Act, each such post-effective amendment
     shall be deemed to be a new registration statement relating to
     the securities offered therein, and the offering of such securi-
     ties at that time shall be deemed to be the initial bona fide
     offering thereof.

               3.   To remove from registration by means of a post-
     effective amendment any of the securities being registered which
     remain unsold at the termination of the offering.

          (b)  The Company hereby undertakes that, for purposes of
     determining any liability under the Securities Act, each filing
     of the Company's annual report pursuant to Section 13(a) or
     Section 15(d) of the Exchange Act (and, where applicable, each
     filing of an employee benefit plan's annual report pursuant to
     Section 15(d) of the Exchange Act) that is incorporated by
     reference in the registration statement shall be deemed to be a
     new registration statement relating to the securities offered
     therein, and the offering of such securities at that time shall
     be deemed to be the initial bona fide offering thereof.

          (c)  Insofar as indemnification for liabilities arising
     under the Securities Act may be permitted to directors, officers
     and controlling persons of the Company pursuant to the provisions
     described under Item 15 above, or otherwise, the Company has been
     advised that in the opinion of the Commission such  indemnifica-
     tion is against public policy as expressed in the Securities Act,
     and is, therefore, unenforceable.  In the event that a claim for
     indemnification against such liabilities (other than the payment
     by the Company of expenses incurred or paid by a director,
     officer or controlling person of the Company in the successful
     defense of any action, suit or proceeding) is asserted by such
     director, officer or controlling person in connection with the
     securities being registered, the Company will, unless in the
     opinion of its counsel the matter has been settled by controlling
     precedent, submit to a court of appropriate jurisdiction the
     question whether such indemnification by it is against public
     policy as expressed in the Securities Act and will be governed by
     the final adjudication of such issue.


                                 SIGNATURES
   
               Pursuant to the requirements of the Securities Act of
     1933, the registrant certifies that it has reasonable grounds to
     believe that it meets all of the requirements for filing on Form
     S-3 and has duly caused this amendment to its registration
     statement to be signed on its behalf by the undersigned, thereun-
     to duly authorized, in Savannah, Georgia on this 9th day of
     May, 1996.    

                                        SAVANNAH FOODS & INDUSTRIES, INC.

                                                    
                                        By /s/  WILLIAM W. SPRAGUE    
                                           ---------------------------
                                               William W. Sprague
                                               President and Chief
                                               Executive Officer

   
               Pursuant to the requirements of the Securities Act of
     1933, this amendment has been signed below by the following persons 
     in the capacities indicated on the 9th day of May, 1996.    

     Signature                                       Title
               
     /s/  WILLIAM W. SPRAGUE, III       
     _______________________________
     William W. Sprague, III                   President and Chief
                                               Executive Officer

     /s/  C. RICHARD DONNELLY      
     _______________________________
     C. Richard Donnelly                       Senior Vice President
                                               President - Savannah
                                               Foods Industrial, Inc.

     /s/  GREGORY H. SMITH              
     _______________________________
     Gregory H. Smith                          Senior Vice President
                                               Chief Financial Officer
                                               and Treasurer

     /s/  F. SPRAGUE EXLEY              
     ________________________________
     F. Sprague Exley                          Senior Vice President Human 
                                               Resources and Administration
                                               and Assistant Secretary

     /s/  JAMES M. KELLY           
     ________________________________
     James M. Kelley                           Senior Vice President
                                               President - Dixie Crys-
                                               tals(R) Brands, Inc.

     /s/  DAVID H. ROUCHE               
     _________________________________
     David H. Roche                            Senior Vice President
                                               President and Chief Oper-
                                               ating Officer -Michigan
                                               Sugar Company

     /s/  BENJAMIN A. OXNARD, JR.       
     ________________________________
     Benjamin A. Oxnard, Jr.                   Senior Vice President - Raw 
                                               Sugar
   
     /s/  J. ERIC STORY                        Corporate Controller
     _________________________________
     J. Eric Story    

     /s/  DALE C. CRITZ                 
     __________________________________
     Dale C. Critz                             Director

     /s/  ARTHUR M. GIGNILLIAT, JR.          
     __________________________________
     Arthur M. Gignilliat, Jr.                 Director

     /s/  ROBERT S. JEPSON, JR.         
     __________________________________
     Robert S. Jepson, Jr.                     Director

     /s/  ARNOLD TENENBAUM              
     __________________________________
     Arnold Tenenbaum                          Director

     /s/  W. WALDO BRADLEY              
     ___________________________________
     W. Waldo Bradley                          Director

     /s/  JOHN D. CARSWELL              
     ___________________________________
     John D. Carswell                          Director
        

     ___________________________________
     Hugh M. Tarbutton                         Director

     /s/  R. EUGENE CARTLEDGE      
     ____________________________________
     R. Eugene Cartledge                       Director

       
    
     ____________________________________
     Lee B. Durham, Jr.                        Director

     /s/  ROBERT L. HARRISON            
     ____________________________________
     Robert L. Harrison                        Director



                               EXHIBIT INDEX

     Exhibit No.              Description
   

     3(i)*          Certificate of Incorporation with Amendments
                    adopted through May 24, 1990.

     3(ii)*         By-Laws of the Company.

     5.1            Opinion of Skadden, Arps, Slate, Meagher & Flom

     23.1           Consent of Price Waterhouse LLP.

     23.2           Consent of Skadden, Arps, Slate, Meagher & Flom
                    (included in Exhibit 5.1)
    
     99.1           Benefit Trust Agreement.

       

   
*  Previously filed.
    



   
                                EXHIBIT 5.1
    


                                      April 29, 1996

    
     Savannah Foods & Industries, Inc.        
     2 East Bryan Street
     Savannah, Georgia 31401

                    Re:  Savannah Foods & Industries, Inc. 
                         Registration Statement on Form S-3            
          

     Ladies and Gentlemen:

               We have acted as special counsel to Savannah Foods &
     Industries, Inc., a Delaware corporation (the "Company"), in
     connection with the public offering by the Savannah Foods &
     Industries, Inc. Benefit Trust (the "Benefit Trust") of up to
     2,500,000 shares (the "Shares") of the Company's common stock,
     par value $0.25 per share (the "Common Stock"), which are the
     subject matter of a registration statement on Form S-3 (No. 333-
     02005)(the "Registration Statement") filed on March 27, 1996 with
     the Securities and Exchange Commission (the "Commis sion") under
     the Securities Act of 1933, as amended (the "Act").

               This opinion is being furnished in accordance with the
     requirements of Item 601(b)(5) of Regulation S-K under the Act.

               In connection with this opinion, we have examined
     originals or copies, certified or otherwise identified to our
     satisfaction, of (i) the Registration Statement; (ii) the Benefit
     Trust Agreement, dated as of March 14, 1996, between the Company
     and Wachovia Bank of North Carolina, N.A., as trustee (the
     "Trustee"); (iii) the Stock Purchase Agreement, dated as of March
     14, 1996, between the  Company and the Trustee, (iv) a specimen
     certificate representing the Common Stock; (v) the Certificate of
     Incorporation of the Company, as presently in effect; (vi) the
     By-Laws of the Company, as presently in effect; and (vii) certain
     resolutions of the Board of Directors of the Company relating to
     the issuance and sale of the Shares and related matters.  We have
     also examined originals or copies, certified or otherwise identi-
     fied to our satisfaction, of such records of the Company and such
     agreements, certificates of public officials, certificates of
     officers or other representatives of the Company and others, and
     such other documents, certificates and records as we have deemed
     necessary or appropriate as a basis for the opinions set forth
     herein.

               In our examination, we have assumed the legal capacity
     of all natural persons, the genuineness of all signatures, the
     authenticity of all documents submitted to us as originals, the
     conformity to original documents of all documents submitted to us
     as certified, conformed or photostatic copies and the authentici-
     ty of the originals of such latter documents.  In making our
     examination of documents executed or to be executed by parties
     other than the Company, we have assumed that such parties had or
     will have the power, corporate or other, to enter into and
     perform all obligations thereunder and have also assumed the due
     authorization by all requisite action, corporate or other, and
     execution and delivery by such parties of such documents and the
     validity and binding effect thereof.  As to any facts material to
     the opinions expressed herein which we have not independently
     established or verified, we have relied upon statements and
     representations of officers and other representatives of the
     Company and others.

               Members of our firm are admitted to the bar in the
     State of Delaware, and we do not express any opinion as to the
     laws of any other jurisdiction.

               Based upon and subject to the foregoing, we are of the
     opinion that the Shares have been duly authorized and validly
     issued and are fully paid and nonassessable.

               We hereby consent to the filing of this opinion with
     the Commission as an exhibit to the Registration Statement.  We
     also consent to the reference to our firm under the caption
     "Legal Matters" in the Registration Statement.  In giving this
     consent, we do not thereby admit that we are included in the
     category of persons whose consent is required under Section 7 of
     the Act or the rules and regulations of the Commission.

                                   Very truly yours,

                                   /s/ SKADDEN, ARPS, SLATE,
                                       MEAGHER & FLOM
    




                                EXHIBIT 23.1


                     CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the incorporation by reference in the
     Prospectus constituting part of this Registration Statement on
     Form S-3 of our report dated November 17, 1995 appearing on page
     14 of Savannah Foods & Industries, Inc.'s Annual Report on Form
     10-K for the year ended October 1, 1995.  We also consent to the
     references to us under the heading "Experts" in such Prospectus. 

     Price Waterhouse LLP

     Atlanta, Georgia
     May 10, 1996    




                                EXHIBIT 99.1


                     SAVANNAH FOODS & INDUSTRIES, INC.
                          BENEFIT TRUST AGREEMENT

               BENEFIT TRUST AGREEMENT ("Trust Agreement"), dated
     March 14, 1996, by and between Savannah Foods & Industries, Inc.,
     a Delaware corporation (the "Company"), and Wachovia Bank of
     North Carolina, N.A., as trustee of the Trust created hereby (the
     "Trustee").

               WHEREAS, the Company and its subsidiaries and affili-
     ates (collectively, the "Corporation") are or may become obligat-
     ed in respect of their existing compensation and benefit plans,
     agreements, programs and arrangements listed on Exhibit A at-
     tached hereto and such existing and future plans,  agreements,
     programs and arrangements as may hereafter be listed on said
     Exhibit A (the plans, agreements, programs and arrangements
     listed on said Exhibit A from time to time being collectively
     referred to herein as the "Plans") to make payments to or contri-
     butions on behalf of past, present or future employees or their
     beneficiaries; and

               WHEREAS, for purposes of providing a source of funds
     for the satisfaction, in whole or in part, of the obligations of
     the Corporation under the Plans, the Company desires to establish
     a trust (the "Trust"), which is intended to constitute a grantor
     trust within the meaning of section 671 of the Internal Revenue
     Code of 1986, as amended (the "Code"), the assets of which shall
     be subject to the claims of the Company's existing or future
     creditors;

               NOW, THEREFORE, in consideration of the mutual agree-
     ments contained herein and for other good and valuable consider-
     ation, the parties hereto agree as follows:

                                 ARTICLE I.

                            PURPOSE OF THE TRUST

               SECTION 1.1  Purpose.  The purpose of the Trust is to
     hold equity securities of the Company ("SF Securities") or other
     property as herein provided as a source of funds to satisfy the
     Corporation's obligations under the Plans.  The Corporation shall
     continue to be liable to make all payments required to be made by
     the Corporation under the terms of the Plans to the extent such
     payments have not been made pursuant to this Trust Agreement. 
     Distributions made from the Trust in  respect of the Plans
     pursuant to Section 3.1 shall, to the extent of such distribu-
     tions, satisfy the Corporation's obligations under the Plans.

                                ARTICLE II.

                         TRUST AND THE TRUST CORPUS
   
               SECTION 2.1  Delivery of Funds and Common Stock.  (a)
     Concurrently with the execution of this Trust Agreement, the
     Company is selling to the Trustee 2,500,000 shares (the "Acquired 
     Shares") of common stock of the Company, par value $0.25 per 
     share ("Common Stock"), pursuant to the terms of a Stock Purchase 
     Agreement, dated the date hereof, between the Company and the 
     Trustee (the "Stock Purchase Agreement"), such Acquired Shares 
     to constitute collateral for the repayment of the Note (as defined 
     below) until released from collateral as provided herein and 
     otherwise to be administered and disposed of by the Trustee as 
     provided herein.  Concurrently with the execution of this Trust 
     Agreement, and pursuant to the terms of the Stock Purchase Agreement, 
     the Trustee, at the direction of the Company, is delivering to the 
     Company, on behalf of the Trust, a Note (the "Note") of the Trust 
     in the original principal amount of $26,875,000, in payment of
     the purchase price for the Acquired Shares.    

               (b)  The Company may sell or otherwise deliver to the
     Trustee additional amounts of cash or Cash Equivalents (as
     defined in Section 2.3 hereof) or SF Securities to be held in
     trust hereunder; provided, however, that the Company shall be
     obligated to make the contributions specified in Section 2.2
     hereof.    

               SECTION 2.2  Contributions to Repay Trust Indebtedness. 
     The Company shall contribute to the Trust in cash an amount
     which, when added to cash dividends received by the Trust in
     respect of Acquired Shares (or other SF Securities, as the case
     may be) and not previously applied under this Section 2.2, shall
     enable the Trustee to make all payments of principal and interest
     due under the Note (or other indebtedness of the Trust relating
     to the acquisition of SF Securities, as the case may be) on a
     timely basis or to make prepayments of such principal or inter-
     est.  The Trustee shall apply all dividends and earnings paid in
     respect of Acquired Shares (or other SF Securities) to the
     payment of principal and interest under the Note (or such other
     indebtedness, as the case may be).  To the extent the Company
     fails to make any contribution required under this Section 2.2,
     or to the extent the Company notifies the  Trustee that it wishes
     to prepay any principal or interest under the Note (or such other
     indebtedness) without making a contribution hereunder, such
     contribution shall be deemed to have been made in the form of
     forgiveness of principal and interest then due and owing on the
     Note and such other indebtedness (or forgiveness of principal and
     interest to the extent of such prepayment, as the case may be). 
     The Trustee shall be accountable for all contributions received
     by it, but shall have no duty to require any contributions to be
     made to it.

               SECTION 2.3  Trust Corpus.  As used herein, the term
     "Trust Corpus" shall mean any cash or Cash Equivalents or SF
     Securities delivered to the Trustee as described in Section 2.1
     or 2.2 hereof, together with any earnings thereon or any proceeds
     from the disposition thereof, plus any cash or Cash Equivalents
     or SF Securities sold or otherwise delivered thereafter pursuant
     to Section 2.1 or 2.2  hereof, together with any earnings thereon
     or any proceeds from the disposition thereof (and less such
     amounts distributed from the Trust pursuant to the terms hereof). 
     As used herein, the term "Cash Equivalents" shall mean securities
     issued or directly and fully guaranteed by the United States or
     any agency or instrumentality thereof (provided that the full
     faith and credit of the United States is pledged in support
     thereof) having maturities of less than one year from the date of
     acquisition.  The Trust Corpus shall at all times be limited to
     SF Securities and cash or Cash Equivalents.

                                ARTICLE III.

                        RELEASE OF THE TRUST CORPUS

               SECTION 3.1  Use of Assets.  1.  In accordance with the
     provisions hereof, the Trustee shall apply the Trust Corpus as
     directed by the Company (1) to the payment of any indebtedness
     (including the Note) of the Trust which is then outstanding, in
     accordance with the terms thereof, (2) on behalf  of the Corpora-
     tion to the satisfaction of the Corporation's obligations under
     the Plans, (3) to the reimbursement of payments made by the
     Corporation in satisfaction of its obligations under the Plans or
     (4) to the acquisition of additional SF Securities; provided,
     however, that the Trustee shall not be required to apply the
     Trust Corpus in the manner described in clauses (2) - (4) above
     during the period that the Company exercises its right to prevent
     the Trustee from disposing of SF Securities pursuant to Section
     4.3, if and to the extent that, at the time the Company's direc-
     tion to so apply the Trust Corpus is received by the Trustee, the
     Trust Corpus does not contain sufficient cash or Cash Equivalents
     to comply with the Company's direction without disposing of SF
     Securities.  A direction by the Company to apply the Trust Corpus
     for a purpose described in clause (2) or (3) above may include a
     direction to deliver SF Securities in kind or to dispose of SF
     Securities and apply the proceeds therefrom for such purpose.

                    2.  Except as provided in Sections 3.1(a) and 4.3,
     the Company shall have no power to direct the Trustee to take or
     omit to take any action with respect to the Trust Corpus.

               SECTION 3.2  Release from Collateral.  On each date on
     which payment is made (or deemed to have been made) of any
     principal amount of the Note (a "Principal Payment Date"), the
     following number of Acquired Shares (and related collateral)
     shall be released from collateral: the number of Acquired Shares
     held in the Trust as collateral immediately prior to the Princi-
     pal Payment Date multiplied by a fraction, the numerator of which
     is the amount of the principal payment made (or deemed to have
     been made) on such date and the denominator of which is the
     principal amount of the Note outstanding immediately prior to
     such principal payment.  Any shares of SF Securities subsequently
     acquired by the Trust with borrowed funds or other indebtedness
     of the Trust (and related collateral) shall be released from
     collateral in a manner consistent with the immediately preceding
     sentence.  The Acquired Shares, SF Securities and related collat-
     eral released pursuant to this Section 3.2 (the "Released Collat-
     eral") shall be contributed to the trust established under a Plan
     or, in the case of any Plan under which no trust has been estab-
     lished, directly to Participants (or Beneficiaries, if appropri-
     ate) in accordance with the directions of the Company.  Upon
     receiving directions from the Company, the Trustee shall sell any
     Released Collateral and transfer the proceeds of such sale to the
     trust established under such Plan or, in the case of any Plan
     under which no trust has been established, to such Plan's Partic-
     ipants (or Beneficiaries, if appropriate).  Any such sale shall
     be made in the manner which the Trustee determines will produce
     the greatest yield (after transaction costs), and may be made in
     the open market or in a private transaction, including (with the
     Company's consent) a sale to the Company.

               SECTION 3.3  Deliveries to Creditors of the Corpora-
     tion.  It is the intent of the parties hereto that the Trust
     Corpus is and shall remain at all times subject to the claims of
     the general creditors of the Company.  Accordingly, neither the
     Trustee nor the Company shall create a security interest in the
     Trust Corpus in favor of the Plans, any participant therein
     (each, a "Participant") (or any beneficiary of such Participant)
     (each, a "Beneficiary")) or any creditor.  If the Trustee re-
     ceives the notice provided for in Section 3.4, or if the Trustee
     otherwise receives actual notice that the Company is insolvent or
     bankrupt as defined in Section 3.4, the Trustee shall make no
     further distributions of the Trust Corpus as directed by the
     Company but shall deliver the entire amount of the Trust Corpus
     only as a court of competent jurisdiction, or duly appointed
     receiver or other person authorized to act by such a court, may
     direct.  The Trustee shall resume distribution of the Trust
     Corpus as directed by the Company under the terms hereof, upon no
     less than 30 days' advance notice to the Company, if the Trustee
     determines that the Company was not, or is no longer, bankrupt or
     insolvent.  Such determination shall be made in a timely fashion,
     and shall be based upon a decision of a court of competent
     jurisdiction, a report of a nationally recognized appraisal firm
     or a certification by the Chief Executive Officer of the Company
     or a determination of the Board of Directors of the Company (the
     "Board").  Unless the Trustee has actual knowledge of the
     Company's bankruptcy or insolvency, the Trustee shall have no
     duty to inquire whether the Company is bankrupt or insolvent.

               SECTION 3.4  Notification of Bankruptcy or Insolvency. 
     The Company shall advise the Trustee promptly in writing of the
     Company's bankruptcy or insolvency.  The Company shall be deemed
     to be bankrupt or insolvent upon the occurrence of any of the
     following:

                         a.  the Company shall make an assignment
         for the benefit of creditors, file a petition in bank-
         ruptcy, petition or apply to any tribunal for the ap-
         pointment of a custodian, receiver, liquidator, seques-
         trator, or any trustee for it or a substantial part of
         its assets, or shall commence any case under any bank-
         ruptcy, insolvency, reorganization, arrangement, read-
         justment of debt, dissolution, liquidation or similar law
         or statute of any jurisdiction (federal or state), wheth-
         er now or hereafter in effect; or if there shall have
         been filed any such petition or application, or any such
         case shall have been commenced against it, in which an
         order for relief is entered or which remains undismissed
         for a period of 120 days; or the Company by any act or
         omission shall indicate its consent to, approval of or
         acquiescence in any such petition, application or case or
         order for relief or to the appointment of a custodian,
         receiver or any trustee for it or any substantial part of
         any of its property, or shall suffer any such custodian-
         ship, receivership or trusteeship to continue undis-
         charged for a period of 120 days; or

                         b.  The Company shall generally not pay
         its debts as such debts become due or shall cease to pay
         its debts generally in the ordinary course of business.

                                ARTICLE IV.

                        ADMINISTRATION OF TRUST FUND

               SECTION 4.1  Trustee.  (a)  The duties and responsibil-
     ities of the Trustee shall be limited to those expressly set
     forth in this Trust Agreement and the Stock Purchase Agreement,
     and no implied covenants or obligations shall be read into this
     Trust Agreement against the Trustee.

                    (b)  If, under circumstances described in Section
     3.4 or otherwise, all or any part of the Trust Corpus is at any
     time attached, garnished, or levied upon by any court order, or
     in case the payment, assignment, transfer, conveyance or delivery
     of any such property shall be stayed or enjoined by any court
     order, or in case any order, judgment or decree shall be made or
     entered by a court affecting such property or any part thereof,
     then and in any of such events the Trustee is authorized, in its
     sole discretion, to rely upon and comply with any such order,
     writ, judgment or decree, and it shall not be liable to the
     Corporation, any Plan or any Participant or Beneficiary by reason
     of such compliance even though such order, writ, judgment or
     decree subsequently may be reversed, modified, annulled, set
     aside or vacated.

                    (c)  The Trustee or its agent shall maintain such
     books, records and accounts as may be necessary for the proper
     administration of the Trust Corpus, and shall render to the
     Company, within 30 days of the end of each calendar quarter,
     commencing with the calendar quarter ending March 31, 1996, until
     the termination of the Trust (and on the date of such termination
     or as promptly as practicable thereafter), an accounting with
     respect to the Trust Corpus as of the end of the then most recent
     calendar quarter (and as of the date of such termination).

                    (d)  The Trustee shall not be liable for any act
     taken or omitted to be taken hereunder if taken or omitted to be
     taken by it in good faith.  The Trustee shall also be fully
     protected in relying upon any notice or instruction given hereun-
     der which it in good faith believes to be genuine and executed
     and delivered in accordance with this Trust.

                    (e)  The Trustee may consult with legal counsel to
     be selected by it, including counsel to the Company, and the
     Trustee shall not be liable for any action taken or omitted to be
     taken by it in good faith in accordance with the advice of such
     counsel.

                    (f)  The Trustee shall be reimbursed by the
     Company for its reasonable expenses incurred in connection with
     the performance of its duties hereunder and shall be paid reason-
     able fees for the performance of such duties.  Any amounts
     payable to the Trustee under this paragraph (f) may be payable
     from the Trust Corpus if not paid by the Company.

                    (g)  Except for any damages, losses, claims or
     expenses resulting from the Trustee's gross negligence or willful
     misconduct, the Company agrees to indemnify and hold harmless the
     Trustee from and against any and all damages, losses, claims or
     expenses as incurred (including reasonable expenses of investiga-
     tion and reasonable fees, charges and disbursements of counsel to
     the Trustee and any taxes imposed on the Trust Corpus or income
     of the Trust) arising out of or in connection with the perfor-
     mance by the Trustee of its duties hereunder.  Without limiting
     the generality of the foregoing, the Trustee shall be under no
     liability to any person for any loss of any kind which may result
     by reason of any action taken by it pursuant to Section 4.4 or
     (2) by reason of its exercising or failing to exercise any power
     or authority under Section 4.4.

                    (h)  Subject to the provisions of this Trust
     Agreement, the Trustee shall have the following additional powers
     and authority, in furtherance of the purpose of the Trust as
     described in Section 1.1, with respect to property constituting a
     part or all of the Trust Corpus:

                         a.  At the direction of the Company, to
         acquire and hold SF Securities and cash or Cash Equiva-
         lents; to sell, exchange or transfer any such property at
         public or private sale for cash or on credit and grant
         options for the purchase or exchange thereof;

                         b.  To exercise any conversion privilege
         or subscription right available in connection with any
         such property; to oppose or to consent to the reorganiza-
         tion, consolidation, merger or readjustment of the fi-
         nances of any corporation, company or association, or to
         the sale, mortgage, pledge or lease of the property of
         any corporation, company or association, any of the secu-
         rities of which may at any time be held in the Trust and
         to do any act with reference thereto, including the exer-
         cise of options, the making of agreements or subscrip-
         tions and the payment of expenses, assessments or sub-
         scriptions, which may be deemed necessary or advisable in
         connection therewith, and to hold and retain any securi-
         ties or other property which it may so acquire;

                         c.  To commence or defend suits or legal
         proceedings and to represent the Trust in all suits or
         legal proceedings; to settle, compromise or submit to
         arbitration, any claims, debts or damages, due or owing
         to or from the Trust;

                         d.  To exercise, personally or by general
         or limited power of attorney, any right, including the
         right to vote, appurtenant to any SF Securities or other
         property; to enter into any voting agreement or voting
         trust, which voting agreement or voting trust shall be
         binding upon any successor trustee but shall not survive
         as to any SF Securities disposed of for value by the
         Trustee;

                         e.  To engage legal counsel, including
         counsel to the Company, or any other suitable agents, to
         consult with such counsel or agents with respect to the
         construction of this Trust Agreement, the duties of the
         Trustee hereunder, the transactions contemplated by this
         Trust Agreement or any act which the Trustee proposes to
         take or omit to take, to rely upon the advice of such
         counsel or agents, and to pay its reasonable fees, ex-
         penses and compensation;

                         f.  To register any securities held by it
         in its own name or in the name of any custodian of such
         property or of its nominee, including the nominee of any
         system for the central handling of securities, with or
         without the addition of words indicating that such secu-
         rities are held in a fiduciary capacity, to deposit or
         arrange for the deposit of any such securities with such
         a system and to hold any securities in bearer form;

                         g.  At the direction of the Company, to
         make, execute and deliver, as Trustee, any and all deeds,
         leases, notes, bonds, guarantees, mortgages, conveyances,
         contracts, waivers, proxies, releases or other instru-
         ments in writing necessary or proper for the exercise of
         any of the foregoing powers; and

                         h.  To take any other action necessary or
         advisable in furtherance of the foregoing powers and the
         purposes of this Trust.

               SECTION 4.2  Successor Trustee.  The Trustee may resign
     and be discharged from its duties hereunder at any time by giving
     to the Company notice in writing of such resignation specifying a
     date (not less than 30 days after the giving of such notice) when
     such resignation shall take effect.  Promptly after such notice,
     the Company shall appoint an independent financial institution as
     successor trustee, such trustee to become Trustee hereunder upon
     the resignation date specified in such notice.  The Trustee shall
     continue to serve until its successor accepts the trust and
     receives delivery of the Trust Corpus.  The Company may at any
     time substitute an independent financial institution as successor
     trustee by giving 15 days' notice thereof to the Trustee then
     acting; provided, however, that, during the pendency of and
     within six (6) months following the cessation of a Potential
     Change in Control (as defined in Section 5.2(d)) and following a
     Change in Control (as defined in Section 5.2(c)), such substitu-
     tion must be approved in writing by at least two-thirds (2/3) of
     the Participants (and Beneficiaries of then-deceased Partici-
     pants) in the Section 4.5 Plans other than Section 4.5 Plans
     maintained for the benefit of non-employee directors of the
     Company.  In the event of such removal or resignation, the
     Trustee shall duly file with the Company a written statement or
     statements of account as provided in Section 4.1(c) for the
     period since the last previous quarterly accounting of the Trust,
     and if written objection to such account is not filed within 90
     days, the Trustee shall to the maximum extent permitted by
     applicable law be forever released and discharged from all
     liability and accountability with respect to the propriety of its
     acts and transactions shown in such account.

               SECTION 4.3  Limitations on Sales.   Except as other-
     wise provided in Section 3.1(a) or 4.4(b) hereof, the Trustee
     shall not sell, exchange or transfer any SF Securities or grant
     any option for the purchase or exchange of any SF Securities
     (each a "Securities Transaction") unless the Trustee shall have
     given the Company 10 business days' prior notice of such Securi-
     ties Transaction.  The Trustee's notice shall state with respect
     to such Securities Transaction (i) the amount of SF Securities
     involved, (ii) whether such Securities Transaction will be
     effected through the public markets and (iii) the date such
     Securities Transaction is proposed to be entered into.  If the
     Company is advised in writing by a recognized independent invest-
     ment banking firm that such Securities Transaction would adverse-
     ly affect any financing by the Company that had been contemplated
     by the Company prior to the receipt of such notice or if the
     Company determines in its good faith judgment that such Securi-
     ties Transaction would require the Company to disclose material
     information which the Company has a bona fide business purpose
     for preserving as confidential or that the Company is unable to
     comply with SEC requirements prior to such Securities Transac-
     tion, the Company may give notice to the Trustee not to effect
     such Securities Transaction prior to the date specified in the
     Trustee's notice.  Upon receipt of such a notice from the Compa-
     ny, the Trustee shall not effect such Securities Transaction for
     a period not to exceed 120 days from the date of the Company's
     notice or such lesser period as shall be specified in the
     Company's notice.

               SECTION 4.4  Voting and Tendering of Common Stock.

               (a)  Voting of Common Stock.  As more fully set forth
     herein, the manner in which shares of Common Stock held by the
     Trust are to be voted on each matter brought before an annual or
     special stockholders' meeting of the Company shall be exercised
     by the Trustee based upon the voting provisions contained in the
     Company's ESOP (or any successor or substitute employee benefit
     plan of the Company which the Company and the Trustee agree shall
     serve as the basis for implementing the provisions of this
     Section 4.4) (such plan being referred to herein as the "Stock
     Plan").  Not less than seventy-two (72) hours prior to each such
     meeting of stockholders, the Company shall cause the trustee of
     the Stock Plan to furnish to the Trustee a document setting forth
     the aggregate votes to be cast on each matter by such trustee
     with respect to shares of Common Stock (and securities convert-
     ible into Common Stock) held by the Stock Plan as of the record
     date for such stockholders' meeting, such votes to be based upon
     the instructions received as of such time from Stock Plan Partic-
     ipants and otherwise in accordance with the provisions of the
     Stock Plan then in effect, but without regard to any failure on
     the part of such trustee to follow such instructions or otherwise
     to abide by such provisions by reason of, for example, its
     fiduciary obligations under the Employee Retirement Security Act
     of 1974, as amended ("ERISA").  Upon timely receipt of such
     document by the Trustee, the Trustee shall on each such matter
     vote the number of shares (including fractional shares) of Common
     Stock held by the Trust in the same proportion as shares of
     Common Stock (and securities convertible into Common Stock) held
     by the Stock Plan are to be voted on such matter, based upon the
     preceding provisions of this Section 4.4(a).

               (b)  Tender or Exchange of Common Stock.  As more fully
     set forth herein, the tender or exchange of shares of Common
     Stock (and securities convertible into Common Stock) shall be
     exercised by the Trustee based upon the tender or exchange
     provisions contained in the Company's Stock Plan.  Not less than
     seventy-two (72) hours prior to the scheduled expiration date of
     a tender or exchange offer for Shares of Common Stock, the
     Company shall cause the trustee of the Stock Plan to furnish to
     the Trustee a document setting forth the number and percentage of
     shares of Common Stock (and securities convertible into Common
     Stock) held by the Stock Plan which will be tendered or ex-
     changed, such number and percentage to be based upon the instruc-
     tions received from Stock Plan Participants and otherwise in
     accordance with the provisions of the Stock Plan then in effect,
     but without regard to any failure on the part of such trustee to
     follow such instructions or otherwise to abide by such provisions
     by reason of, for example, its fiduciary obligations under ERISA. 
     In the event the scheduled expiration date of such offer is
     changed, the foregoing provisions of this Section 4.4(b) shall be
     applied to each subsequent scheduled expiration date.  Upon
     timely receipt of such document by the Trustee, the Trustee shall
     tender the number of shares of Common Stock held by the Trust in
     the same proportion as shares of Common Stock (and securities
     convertible into Common Stock) held by the Stock Plan are to be
     tendered or exchanged, based upon the preceding provisions of
     this Section 4.4(b).

               (c)  Nothing in this Section 4.4 shall be construed as
     permitting or requiring the divulging or release to any person
     affiliated with the Company of any confidential instructions
     provided to the trustee of the Stock Plan by individual Stock
     Plan Participants or Beneficiaries.

               SECTION 4.5  Certain Change in Control Provisions. 
     Notwithstanding any other provision hereof, following a Change in
     Control, (defined in Section 5.2(c)), (a) the Plans shall be
     limited to those Plans which, immediately prior to such Change in
     Control, are designated on Exhibit A hereto as "Section 4.5
     Plans" until such time as all liabilities under such Section 4.5
     Plans have been satisfied, (b) benefits under each Section 4.5
     Plan shall be deemed to include payment or reimbursement to each
     Participant or Beneficiary of such Section 4.5 Plan of legal fees
     and other expenses incurred by such Participant or Beneficiary in
     seeking to obtain benefits or otherwise to enforce his or her
     rights under such Section 4.5 Plan, and (c) the Trustee shall
     make payment to a Participant or Beneficiary of any such Section
     4.5 Plan in accordance with written instructions received from
     such Participant or Beneficiary, which instructions shall include
     a certification (i) that such Participant or Beneficiary is
     entitled to payment under the Section 4.5 Plan, (ii) of the
     amount of such payment, (iii) that the Corporation has not made
     payment of such amount, and (iv) that a copy of such instructions
     has been provided to the Company.  Unless the Company objects to
     the payment called for by such instructions within 10 business
     days of its receipt thereof (the bases for such objection by the
     Company being limited to (i) the Company's Insolvency (as defined
     in Section 3.4 hereof) and (ii) the amount of such payment
     clearly not being payable under the appropriate Section 4.5
     Plan), the Trustee shall make payment to the Participant or
     Beneficiary in accordance with such instructions.  In the event
     the Trustee receives such objection within such 10-day period, it
     shall not make payment until receipt of, and then in accordance
     with, written instructions from the Company and the Participant
     or Beneficiary.

                                 ARTICLE V.

                     TERMINATION, AMENDMENT AND WAIVER

               SECTION 5.1  Termination.  The Trust shall be terminat-
     ed on the earlier of the twentieth anniversary of the date hereof
     or the date on which any of the following events occurs (the
     "Termination Date"):  (a) the Corporation's obligations under the
     Plans are satisfied in full; (b) the Trust Corpus is exhausted;
     or (c) such date as may be established by resolution of the
     Board, provided, however, that during the period specified in
     Section 5.2(b) hereof, the Board may not act to terminate the
     Trust.  Upon termination of the Trust, any remaining portion of
     the Trust Corpus shall be applied in the following order:  first,
     to satisfy any outstanding indebtedness of the Trust; second, as
     directed by the Company or its delegate pursuant to Section
     3.1(a); and third, to fund obligations of the Corporation, or
     otherwise provide benefits to current employees of the Corpora-
     tion, under one or more employee benefit plans, agreements,
     programs or arrangements (other than Plans).  In no event shall
     the Company receive any distribution of the Trust Corpus upon
     termination of the Trust, except in repayment of indebtedness to
     the Company incurred by the Trustee or in reimbursement of
     payments made by the Corporation in satisfaction of its obliga-
     tions under the Plans.

               SECTIONS 5.2   Amendment and Waiver.  (a) Prior to a
     Potential Change in Control (as defined in Section 5.2(d), the
     Company and the Trustee may amend this Trust Agreement, including
     Exhibit A attached hereto, which is an integral part of this
     Trust Agreement, by written instrument executed and duly autho-
     rized by the Company and the Trustee; however, no such amendment
     shall accelerate the Termination Date or permit the Company to
     receive any distribution prohibited by the last sentence of
     Section 5.1.

               (b)  During the pendency of and within six (6) months
     following the cessation of a Potential Change in Control (as
     defined in Section 5.2(d)) and following a Change in Control (as
     defined in Section 5.2(c)), this Trust Agreement may be amended
     in the manner and subject to the provisions of Section 5.2(a);
     provided, however, that if any such amendment would be adverse in
     any way to the interests of any Participant or Beneficiary (an
     "Adverse Amendment"), then such amendment must be approved in
     writing by at least two-thirds (2/3) of the Participants (and
     Beneficiaries of then-deceased Participants) in the Section 4.5
     Plans other than Section 4.5 Plans maintained for the benefit of
     non-employee directors of the Company.  For purposes of this
     Section 5.2(b), an Adverse Amendment shall include, but not be
     limited to, (i) an amendment which removes one or more Plans from
     Exhibit A hereto or which would change the status of any Plan as
     a "Section 4.5 Plan"; (ii) any amendment to Sections 2.2, 3.2 or
     4.5 hereof or to this Article V.

               (c)  A "Change in Control" shall be deemed to have
     occurred when and only when the first of the following events
     occurs:

                         a.  any "person" (as that term is used in
         Sections 13(d) and 14(d)(2) of the Securities Exchange
         Act of 1934, as amended (the "Exchange Act"), other than
         (1) any employee plan established by the Corporation,
         (2) the Corporation, (3) an underwriter temporarily hold-
         ing securities pursuant to an offering of such securi-
         ties, or (4) a corporation owned, directly or indirectly,
         by stockholders of the Corporation in substantially the
         same proportions as their ownership of the Corporation)
         is or becomes the beneficial owner, directly or indirect-
         ly, of securities of the Company representing 20% or more
         of the combined voting power of the Company's then out-
         standing voting securities; or

                         b.  during any period of two consecutive
         years, individuals who at the beginning of such period
         constituted the Board and any new director (other than an
         individual whose nomination for election is in connection
         with an actual or threatened election contest relating to
         the election of the directors of the Company, as such
         terms are used in Rule 14a-11 of Regulation 14A under the
         Ex change Act) whose appointment, election, or nomination
         for election by the Company's shareholders, was approved
         by a vote of at least two-thirds (2/3) of the directors
         then still in office who either were directors at the
         beginning of the period or whose appointment, election or
         nomination for election was previously so approved, cease
         for any reason to constitute a majority of the Board; or

                         c.  there is consummated a merger or
         consolidation of the Company or a subsidiary thereof with
         or into any other corporation, other than a merger or
         consolidation which would result in the holders of the
         voting securities of the Company outstanding immediately
         prior thereto holding securities which represent immedi-
         ately after such merger or consolidation more than 80% of
         the combined voting power of the voting securities of
         either the Company or the other entity which survives
         such merger or consolidation or the parent of the entity
         which survives such merger or consolidation; or

                         d.  there is consummated a sale or dispo-
         sition by the Company of all or substantially all the
         Company's assets.

               (d)  A "Potential Change in Control" shall be deemed to
     have occurred if the conditions set forth in any one of the
     following paragraphs shall have been satisfied:

                         (i)  any person (as defined in Section
         5.2(c)(i) above) is or becomes the beneficial owner,
         directly or indirectly, of securities of the Company
         representing fifteen percent (15%) or more of the com-
         bined voting power of the Company's then outstanding
         voting securities; or

                         (ii)  the Company enters into an agree-
         ment, the consummation of which would result in the oc-
         currence of a Change in Control; or

                         (iii)  any person (as defined in Section
         5.2(c)(i) above) publicly announces an intention to take
         or to consider taking actions which, if consummated,
         would constitute or result in a Change in Control; or

                         (iv)  any person (as defined in Section
         5.2(c)(i) above) commences a solicitation (as defined in
         Rule 14a-1 of the General Rules and Regulations under the
         Exchange Act) of proxies or consents which has the pur-
         pose of effecting or would (if successful) result in a
         Change in Control; or

                         (v)  a tender or exchange offer for
         voting securities of the Company, made by a person (as
         defined in Section 5.2(c)(i) above), is first pub lished
         or sent or given (within the meaning of Rule 14d-2(a) of
         the General Rules and Regulations under the Exchange
         Act).

                                 ARTICLE VI

                             GENERAL PROVISIONS

               SECTION 6.1  Certain Provisions Relating to This Trust
     Agreement.  (a)  This Trust Agreement shall be binding upon and
     inure to the benefit of the parties and their respective succes-
     sors and legal representatives.

                    (b)  This Trust Agreement shall be governed by and
     construed in accordance with the laws of Delaware, without
     reference to any provisions of such laws regarding choice of laws
     or conflict of laws.

                    (c)  In the event that any provision of this Trust
     Agreement or the application thereof to any person or circum-
     stances shall be determined by a court of proper jurisdiction to
     be invalid or unenforceable to any extent, the remainder of this
     Trust Agreement, or the application of such provision to persons
     or circumstances other than those as to which it is held invalid
     or unenforceable, shall not be affected thereby, and each other
     provision of this Trust Agreement shall be valid and enforced to
     the fullest extent permitted by law.

               SECTION 6.2  Notices.  Any notice, report, demand or
     waiver required or permitted hereunder shall be in writing and
     shall be given personally, delivered by overnight delivery
     service or sent by telecopier, addressed as follows:

               If to the Company:

                    Savannah Foods & Industries, Inc.
                    2 East Bryan Street
                    Savannah, Georgia  31401
                    Attention:  Senior Vice President, Chief Financial
                                Officer and Treasurer

               If to the Trustee:

                    Wachovia Bank of North Carolina, N.A.
                    P.O. Box 3099
                    Winston-Salem, North Carolina  27150
                    Mail Code NC-31013
                  Attention:       Beverley H. Wood
                                   Senior Vice President

     Notices shall be effective only upon receipt.

               The Company or Trustee may change the address to which
     notices, requests and other communications are to be sent to it
     by giving written notice of such address change to the other
     parties in conformity with this Section 6.2.

               SECTION 6.3  Gender and Number.  Wherever any words are
     used herein in the masculine gender, they shall be construed as
     though they were also used in the feminine gender in all cases
     where they would so apply, and wherever any words are used herein
     in the singular form, they shall be construed as though they were
     also used in the plural form in all cases where they would so
     apply.  Likewise, wherever any words are used herein in the
     plural form, they shall be construed as though they were also
     used in the singular form in all cases where they would so apply.

               SECTION 6.4  Headings.  The headings and subheadings of
     this Agreement have been inserted for convenience of reference
     and are to be ignored in any construction of the provisions
     hereof.

               SECTION 6.5  No Third Party Beneficiaries.  Nothing in
     this Trust, express or implied, is intended to or shall confer on
     any particular person, other than the Company and the Trustee,
     any right, benefit or remedy of any nature whatsoever under or by
     reason of this Trust, and no such person shall have any right,
     title or interest in or any claim to the Trust Corpus except to
     the extent expressly provided in Section 5.1 upon termination of
     this Trust.  In particular, it is the express intent of the
     parties that (i) this Trust shall not form part of any of the
     Plans, (ii) neither any Plan nor any Participant in any of the
     Plans (nor any Beneficiary of such Participant) shall have any
     right, title or beneficial ownership or other interest in or any
     claim (preferred or otherwise) to the Trust Corpus, nor shall any
     such participant have any right to compel, restrain or otherwise
     direct the exercise of the respective powers of Trustee and the
     Company hereunder, it being understood that the rights of each
     such Participant (and Beneficiary) shall be determined in accor-
     dance with the provisions of the Plans and (iii) the Trust Corpus
     shall not be deemed to be held under any trust for the benefit of
     any such Participant (or Beneficiary) or to be collateral securi-
     ty for the performance of the obligations of the Corporation.

               SECTION 6.6  Counterparts.  This Agreement may be
     executed in any number of counterparts, each of which shall be
     deemed to be an original, but all of which together constitute
     but one instrument, which may be sufficiently evidenced by any
     counterpart.

               SECTION 6.7  Directions by Company.  Except as other-
     wise provided herein, all directions by the Company to the
     Trustee shall be effected by any two officers of the Company from
     the group of officers consisting of the Chief Executive Officer,
     Chief Financial Officers, Executive Vice Presidents and Senior
     Vice Presidents.  The Company shall provide to the Trustee an
     incumbency certificate with respect to each member of the forego-
     ing group of officers and, in the absence of actual knowledge to
     the contrary, the Trustee shall be conclusively entitled to rely
     on such certificates as to each such individual's authority to
     provide directions to the Trustee  hereunder.

               IN WITNESS WHEREOF, the parties have caused this
     Agreement to be executed under seal in their respective names by
     their duly authorized officers the day and year first above
     written.

                        SAVANNAH FOODS & INDUSTRIES, INC.

                        By /s/  GREGORY H. SMITH                      
                           Name:   Gregory H. Smith
                           Title:  Senior Vice President, Chief
                                   Financial Officer and Treasurer

                        WACHOVIA BANK OF NORTH CAROLINA, N.A.,
                        solely in its capacity as 
                        trustee under this Trust
                        Agreement

                        By /s/  BEVERLY H. WOOD                       
                           Name:   Beverly H. Wood
                           Title:  Senior Vice President


     EXHIBIT A

                     SAVANNAH FOODS & INDUSTRIES, INC.

                                   PLANS

     Section 4.5 Plans

     1.   Deferred Compensation Plan for Key Employees of Savannah
          Foods & Industries, Inc. and Subsidiaries (effective August
          1, 1990), as amended, and all deferred compensation agree-
          ments or elections made thereunder

     2.   Deferred Compensation Plan for Key Employees of Savannah
          Foods & Industries, Inc. (Amendment and Restatement effec-
          tive August 12, 1983), as amended, and all deferred compen-
          sation agreements or elections made thereunder

     3.   Deferred Compensation Plan for Key Employees of Michigan
          Sugar Company (initially effective January 1, 1985), as
          amended, and all deferred compensation agreements or elec-
          tions made thereunder

     4.   Deferred Compensation Plan for directors of Savannah Foods &
          Industries, Inc. (amended and restated effective August 4,
          1989), as amended, and all deferred compensation agreements
          or elections made thereunder

     5.   Supplemental Executive Retirement Plan (SERP) of Savannah
          Foods & Industries, Inc. and Subsidiaries (Second Amendment
          and Restatement Effective January 1, 1989), as amended, and
          all deferred compensation agreements or elections made
          thereunder

     6.   Deferred Compensation Agreement between Walter C. Scott and
          Savannah Foods & Industries, Inc. (dated December 27, 1984)

     7.   Deferred Compensation Agreement between William W. Sprague,
          Jr. and Savannah Foods & Industries, Inc. (dated October 5,
          1992)

     8.   Deferred Compensation Agreement between Ernest Flegenheimer
          and Michigan Sugar Company (dated September 8, 1992)

     Other Plans

     1.   Savannah Foods & Industries, Inc. Employee Stock Ownership
          Plan, amended and restated effective January 1, 1989

     2.   Retirement Income Plan for Employees of Savannah Foods &
          Industries, Inc., effective July 1, 1934



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission